Barclays Sticks to Their Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Barclays analyst Hassan Al-Wakeel maintains a Hold rating for Fresenius Medical Care AG & Co. KGaA with a price target of €48.00. Al-Wakeel, a 2-star analyst, has a 0.1% average return and a 47.50% success rate. Kepler Capital also issued a Hold rating, while Morgan Stanley maintained a Sell rating on November 10.
Barclays analyst Hassan Al-Wakeel maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €48.00.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
According to TipRanks, Al-Wakeel is a 2-star analyst with an average return of 0.1% and a 47.50% success rate. Al-Wakeel covers the Healthcare sector, focusing on stocks such as Straumann Holding AG, Smith & Nephew, and Sonova Holding AG.
In addition to Barclays, Fresenius Medical Care AG & Co. KGaA also received a Hold from Kepler Capital ‘s Oliver Reinberg in a report issued on November 16. However, on November 10, Morgan Stanley maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).
